Your browser doesn't support javascript.
loading
Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy.
Abbas, Hussein A; Sun, Hanxiao; Pierce, Sherry; Kanagal-Shamanna, Rashmi; Li, Ziyi; Yilmaz, Musa; Borthakur, Gautam; DiPippo, Adam J; Jabbour, Elias; Konopleva, Marina; Short, Nicholas J; DiNardo, Courtney; Daver, Naval; Ravandi, Farhad; Kadia, Tapan M.
Afiliação
  • Abbas HA; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.
  • Sun H; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX.
  • Pierce S; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.
  • Kanagal-Shamanna R; School of Public Health, University of Texas, Houston, TX.
  • Li Z; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.
  • Yilmaz M; Department of Hematopathology, MD Anderson Cancer Center, Houston, TX.
  • Borthakur G; Department of Biostatistics, MD Anderson Cancer Center, Houston, TX.
  • DiPippo AJ; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.
  • Jabbour E; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.
  • Konopleva M; Department of Pharmacy Clinical Programs, MD Anderson Cancer Center, Houston, TX.
  • Short NJ; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.
  • DiNardo C; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.
  • Daver N; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.
  • Ravandi F; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.
  • Kadia TM; Department of Leukemia, MD Anderson Cancer Center, Houston, TX.
Blood Adv ; 7(5): 828-831, 2023 03 14.
Article em En | MEDLINE | ID: mdl-35405739

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos